BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23377986)

  • 1. Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.
    Han B; Sun JM; Ahn JS; Park K; Ahn MJ
    Med Oncol; 2013 Mar; 30(1):479. PubMed ID: 23377986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.
    Herde RF; Kokeny KE; Reddy CB; Akerley WL; Hu N; Boltax JP; Hitchcock YJ
    Am J Clin Oncol; 2018 Jan; 41(1):24-29. PubMed ID: 26270444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid.
    Wang X; Li Y; Duan J; Chen Y; Yuan B; Qi Z; Tan H
    Oncologist; 2019 Jun; 24(6):798-802. PubMed ID: 30413666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior.
    Perkins P; Kemp BL; Putnam JB; Cox JD
    Am J Clin Oncol; 1997 Jun; 20(3):285-8. PubMed ID: 9167755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
    Thomas CF; Tazelaar HD; Jett JR
    Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients.
    Fukai I; Masaoka A; Fujii Y; Yamakawa Y; Yokoyama T; Murase T; Eimoto T
    Ann Thorac Surg; 1999 Jan; 67(1):208-11. PubMed ID: 10086551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report.
    Mei Z; Wang H; Ren S; Wei J; Gu Y
    Medicine (Baltimore); 2018 Nov; 97(47):e13286. PubMed ID: 30461637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
    Ferolla P; Brizzi MP; Meyer T; Mansoor W; Mazieres J; Do Cao C; Léna H; Berruti A; Damiano V; Buikhuisen W; Grønbæk H; Lombard-Bohas C; Grohé C; Minotti V; Tiseo M; De Castro J; Reed N; Gislimberti G; Singh N; Stankovic M; Öberg K; Baudin E
    Lancet Oncol; 2017 Dec; 18(12):1652-1664. PubMed ID: 29074099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung and Thymic Carcinoids.
    Hann CL; Forde PM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchopulmonary carcinoid tumors: Tunisian experience with 115 surgically treated cases].
    Ayadi-Kaddour A; Marghli A; Zairi S; Zribi H; Ismail O; Braham E; Hantous-Zannad S; Kilani T; El Mezni F
    Rev Pneumol Clin; 2015 Dec; 71(6):319-26. PubMed ID: 26195112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality treatment of neuroendocrine tumors of the thymus.
    Dosios T; Nikou GC; Toubanakis C; Filippides T; Papachristou D
    Thorac Cardiovasc Surg; 2005 Oct; 53(5):305-9. PubMed ID: 16208618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent thymic carcinoid tumor in the pleural cavity. 2 cases of long-term survivors.
    Tsuchida M; Yamato Y; Hashimoto T; Saito M; Hayashi J
    Jpn J Thorac Cardiovasc Surg; 2001 Nov; 49(11):666-8. PubMed ID: 11757339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after resection for bronchial carcinoid tumors.
    Ferguson MK; Landreneau RJ; Hazelrigg SR; Altorki NK; Naunheim KS; Zwischenberger JB; Kent M; Yim AP
    Eur J Cardiothorac Surg; 2000 Aug; 18(2):156-61. PubMed ID: 10925223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after surgical resection of pulmonary carcinoid tumors.
    Okereke IC; Taber AM; Griffith RC; Ng TT
    J Cardiothorac Surg; 2016 Mar; 11():35. PubMed ID: 26935588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
    Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
    J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases.
    de Montpréville VT; Macchiarini P; Dulmet E
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):134-41. PubMed ID: 8551758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
    Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
    Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal Metastasis Resulting from Atypical Thymic Carcinoid: A Case Report.
    Wu X; Qi Y; Yang F; Tan M; Lin J
    World Neurosurg; 2018 Mar; 111():373-376. PubMed ID: 29325948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.
    Chong CR; Wirth LJ; Nishino M; Chen AB; Sholl LM; Kulke MH; McNamee CJ; Jänne PA; Johnson BE
    Lung Cancer; 2014 Nov; 86(2):241-6. PubMed ID: 25218177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.